Artículos Científicos en Ingles

Artículos Científicos RSS AJKD

G-481 De Novo NELL-1-Associated Membranous Nephropathy in a Kidney Transplant Recipient

Este artículo no posee resumen

G-480 Natural History Model of Lifetime Burden of Immunoglobulin A Nephropathy (IgAN) in the United States

Este artículo no posee resumen

G-479 Real-World Treatment and Progression of IgA Nephropathy (IgAN) in the United States

Este artículo no posee resumen

G-478 ORIGIN 3: A Phase 3 Trial of Atacicept in IgA Nephropathy

Este artículo no posee resumen

G-477 Elevating Perspectives of Patients (Pts) With Kidney Diseases: A National Kidney Foundation (NKF) KidneyCARE Study Survey

Este artículo no posee resumen

G-485 Infliximab-Associated Secondary Focal Segmental Glomerulosclerosis Presenting With Severe Nephrotic Syndrome

Este artículo no posee resumen

G-486 “I feel trapped. It’s lifelong”: Understanding the Patient Experience of IgAN

Este artículo no posee resumen

G-487 Sibeprenlimab in IgA Nephropathy: Assessment of Target Proteinuria Thresholds in the Phase 3 VISIONARY Trial Interim Analysis

Este artículo no posee resumen

G-495 Time-Averaged Proteinuria > 0.5 g/d Is Associated With Increased Risk of Kidney Failure in Adult Patients With IgAN in the US

Este artículo no posee resumen

G-494 Economic Burden Associated With Focal Segmental Glomerulosclerosis (FSGS) in the US

Este artículo no posee resumen

G-493 A New Therapeutic Approach to Crescentic IgA Nephropathy

Este artículo no posee resumen

G-492 OBSERVE-GN: Obinutuzumab Safety and Effectiveness in Real-world eValuation of Glomerular Nephropathies

Este artículo no posee resumen

G-491 Health Outcome Disparities and Determinants of Progression in a Multiethnic Cohort of IgAN Patients

Este artículo no posee resumen

G-490 COMBO-IGNITE: Real-World Effectiveness and Early Safety Signals of Combination Therapy in IgA Nephropathy

Este artículo no posee resumen

G-489 DNAJB9-Positive Crescentic Fibrillary Glomerulonephritis With Full-House IF: Dialysis-Dependent AKI and Patient-Directed Deferral of Cyclophosphamide

Este artículo no posee resumen

Páginas